Prodeon Medical
Medical device company developing a minimally invasive, investigational procedure to treat lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH). The approach uses a temporary, retrievable nitinol expander implant delivered and removed via flexible cystoscopy to reshape the prostatic urethra (Prostatic Urethral REshaping, PURE). The company conducts multinational clinical studies and disseminates interim and peer-reviewed results.
Industries
N/A
Products
Investigational temporary prostatic urethral expander and delivery/retrieval system
A temporary, nitinol-based implant delivered via a flexible cystoscope and designed to expand the prostatic urethra; the system includes a delivery catheter and a retrieval sheath for removal after a dwell time.
Investigational temporary prostatic urethral expander and delivery/retrieval system
A temporary, nitinol-based implant delivered via a flexible cystoscope and designed to expand the prostatic urethra; the system includes a delivery catheter and a retrieval sheath for removal after a dwell time.
Services
Clinical study operations and site coordination
Conduct of investigational device clinical trials including site engagement, enrollment, randomized study execution and data collection.
Clinical study operations and site coordination
Conduct of investigational device clinical trials including site engagement, enrollment, randomized study execution and data collection.
Expertise Areas
- Minimally invasive urological device development
- Clinical trial management for implantable devices
- Prostatic urethral reshaping procedures
- Preclinical feasibility testing
Key Technologies
- Nitinol-based implantable devices
- Flexible cystoscopy-compatible delivery systems
- Retrieval sheath for removable implants
- Office-based minimally invasive procedure workflows